We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$312M
AUM Growth
+$8.39M
Cap. Flow
+$17M
Cap. Flow %
5.47%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
BOLT icon
Bolt Biotherapeutics
BOLT
+$61.5M

Top Sells

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$20.6M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$19.8M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
+$3.21M
4
ITRM
Iterum Therapeutics
ITRM
+$935K
5
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
+$10.8K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$109M 35.05%
908,708
-174,636
-16% -$19.8M
BOLT icon
2
Bolt Biotherapeutics
BOLT
$7.65M
$62.2M 19.97%
+94,573
New +$61.5M
INZY
3
DELISTED
Inozyme Pharma
INZY
$31.5M 10.11%
1,591,154
– –
PCVX icon
4
Vaxcyte
PCVX
$8.81B
$27.8M 8.91%
1,405,421
-817,549
-37% -$20.6M
AKUS
5
DELISTED
Akouos Inc
AKUS
$24.9M 7.98%
1,794,088
– –
ALGS icon
6
Aligos Therapeutics
ALGS
$45.5M
$19.9M 6.4%
35,062
– –
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$17.1M 5.5%
1,598,379
– –
ARQT icon
8
Arcutis Biotherapeutics
ARQT
$3.3B
$16.5M 5.28%
569,041
-102,675
-15% -$3.21M
ETTX
9
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$2.52M 0.81%
1,176,378
-3,800
-0.3% -$10.8K
ITRM
10
DELISTED
Iterum Therapeutics
ITRM
– –
-63,006
Closed -$935K

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q1 2021 Portfolio in Review

As of Q1 2021, Pivotal bioVenture Partners Investment Advisor held 10 positions worth $312M, up 2.8% from $303M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pivotal bioVenture Partners Investment Advisor deployed $17M of net new capital in Q1 2021, opening 1 new position. Its largest new stake was Bolt Biotherapeutics: 94,573 shares worth $62.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Vaxcyte, an estimated $20.6M trimmed.

  • Pivotal bioVenture Partners Investment Advisor's largest Q1 2021 buy was Bolt Biotherapeutics: 94,573 shares worth $62.2M.
  • Pivotal bioVenture Partners Investment Advisor's biggest Q1 2021 reduction was Vaxcyte, cutting an estimated $20.6M.
  • Pivotal bioVenture Partners Investment Advisor fully exited Iterum Therapeutics in Q1 2021, selling an estimated $935K.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 100% of its $312M portfolio in Q1 2021.
  • Pivotal bioVenture Partners Investment Advisor opened 1 new position and closed 1 in Q1 2021.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value rose 2.8% quarter-over-quarter to $312M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q1 2021, filed 14 May 2021.